Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Blast Crisis × darolutamide × 1 year × Clear all

Sponsor

Conditions

Prostatic Neoplasms 39 Salivary Gland Neoplasms 3 Prostatic Neoplasms, Castration-Resistant 3 Neoplasms 3 Urogenital Neoplasms 2 Prostatic Diseases 2 Non-metastatic Castration-resistant Prostate Cancer 2 Neoplasm Metastasis 2 Metastatic Castration-resistant Prostate Cancer 2 Male Urogenital Diseases 2 Bulbo-Spinal Atrophy, X-Linked 2 Biochemically Recurrent Prostate Cancer 2 Adenocarcinoma 2 Urogenital Diseases 1 Triple Negative Breast Neoplasms 1 Sleep Initiation and Maintenance Disorders 1 Prostate Adenocarcinoma 1 Neoplasms by Site 1 Metastatic Castration-resistant Prostate Neoplasms 1 Metastatic Castration-resistant Prostate Cancer (mCRPC) 1 High-Risk Localized Prostate Cancer 1 Granulosa cell tumor of the ovary 1 Genital Diseases, Male 1 Fatigue 1 Depression 1 Carcinoma, Transitional Cell 1 Carcinoma, Renal Cell 1 Carcinoma, Non-Small-Cell Lung 1 Breast Neoplasms 1

Interventions

Cyclophosphamide 6 ponatinib 5 Methotrexate 5 Mycophenolic Acid 4 merphos 3 Whole-Body Irradiation 3 Tacrolimus 3 Rituximab 3 Peripheral Blood Stem Cell Transplantation 3 Cytarabine 3 Cyclosporine 3 CT-P10 3 venetoclax 2 fludarabine phosphate 2 dexamethasone acetate 2 dexamethasone 21-phosphate 2 bosutinib 2 blinatumomab 2 auricularum 2 Vincristine 2 Etoposide 2 Dexamethasone 2 Calcium Dobesilate 2 Busulfan 2 prednylidene 1 pegfilgrastim 1 nilotinib 1 fludarabine 1 deltacortene 1 belinostat 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡